Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin alpha pseudogene 1 is classified as a *processed pseudogene* related to the family of genes encoding alpha-tubulin, the structural protein subunit of microtubules[1][5]. Unlike protein-coding tubulin alpha genes such as TUBA1A or TUBA1B, TUBAP1 does not generate a functional protein[1][5]. Pseudogenes are typically non-functional segments of DNA that arise from gene duplication or retrotransposition and have lost the ability to encode a protein. There is no evidence that TUBAP1 is involved in microtubule assembly or any known biological process, and it does not act as a drug or therapeutic target. Information about TUBAP1 is sparse in curated genetic and molecular databases, and it should not be confused with active alpha-tubulin genes, which are targets of classic anti-mitotic drugs and implicated in a range of neurological and developmental disorders. Summary of findings: - TUBAP1 is a *pseudogene* and not an active protein or therapeutic target[1][5]. - It does not encode an alpha-tubulin protein nor contribute to cytoskeletal or cell division functions. - There are no known disease associations, biological roles, or FDA-approved drugs interacting with TUBAP1. - The validated functional tubulin alpha genes with strong biological and clinical significance are *TUBA1A* and *TUBA1B*, which are structurally and functionally distinct from TUBAP1[1][5]. If you are seeking information about *alpha-tubulin proteins* or active alpha-tubulin genes as therapeutic targets (e.g., TUBA1A), please clarify, as those genes are structurally and functionally important and widely studied[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin alpha pseudogene 1 (TUBAP1).